Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-07 Sale |
2025-01-08 8:00 pm |
Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO |
5,000 | $60 | $300,004 | 293,054 (Direct) |
View |
| 2024-12-24 Sale |
2024-12-27 8:00 pm |
Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO |
25,000 | $56.19 | $1,404,805 | 217,054 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-03 8:00 pm |
Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO |
15,000 | $67 | $1,005,000 | 242,054 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 8:00 pm |
Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO |
25,000 | $51.6 | $1,289,879 | 257,054 (Direct) |
View |
| 2024-10-28 Sale |
2024-10-30 7:30 pm |
Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO |
25,000 | $53.54 | $1,338,559 | 282,054 (Direct) |
View |
| 2024-09-27 Sale |
2024-09-27 7:30 pm |
Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO |
25,000 | $46.31 | $1,157,641 | 307,054 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 8:10 pm |
N/A 2035-01-01 |
Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO |
364,500 | $0 | 581,554 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:49 pm |
N/A 2034-01-01 |
Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO |
356,500 | $0 | 356,500 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:30 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer |
310,000 | $0 | 310,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:21 pm |
N/A 2032-01-02 |
Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer |
354,250 | $0 | 354,250 (Direct) |
View |
Ownership |
2021-06-10 7:02 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer |
0 | $0 | 2,276,612 (Direct) |
View |